1Ezzati M, Henley S J, Thun MJ, et al. Role of smoking in global and regional cardiovascular mortality [ J ]. Circulation, 2005,112 (4) :489 -497.
2Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifi- able risk factors associated with myocardial infarction in 52 countries ( the INTERHEART study) : case-control study [ J ]. Lancet, 2004,364 (9438) :937 - 952.
3Erhardt L. Cigarette smoking:an undertreated risk factor for cardiovascular disease[ J]. Atherosclerosis ,2009,205 ( 1 ) :23 - 32.
4Godtfredsen NS, Osler M, Vestbo J, et al. Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976 - 1998 : a pooled cohort study [ J ]. J Epidemiol Community Health,2003,57(6) :412 -416.
5Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and out come than does brachi- al pressure: the Strong Heart Study [J]. Hypertension, 2007,50 (1) ,197 -203.
8Takazawa K, Kobayashi H, Shindo N, et al. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave [ J ]. Hypertens Res,2007,30(3) :219 -228.
10Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part II : association with cardiovascular risk fac- tors and diseases. A statement by the Working Group on Endothe- lins and Endothelial Factors of the European Society of Hyperten- sion [ J ]. J Hypertens ,2005,23 (2) :233 - 246.
二级参考文献36
1Yoshimura M, Yasue H, Nakayama M, et al, A missense Glu 298 Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese[J]. Hum Genet, 1998,103(1) :65 - 69.
2Hingorani AD, Liang CF, Fatibene J, et ak A common variant of the endothelial nitric oxide synthase(Glu 298→Asp)is a major risk factor for coronary artery disease in the UK [J]. Circulation,1999, 100(14) : 1515 - 1520.
3Colombo MG, Andreassi MG, Paradossi U, et al, Evidence for association of a common variant of the endothelial nitric oxide synthase gene(Glu 298→Asp polymorphism)to the presence, extent, and severity of coronary artery disease [J].Heart, 2002, 87(6):525-528.
5Shimasaki Y, Yasue H, Yoshimura M, et al. Associon of the missense Glu 298 Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction [J]. J Am Coil Cardiol, 1998, 31(7) : 1506 - 1510.
6Yoshimura M, Yasue H, Nakayama M, et al. A missense glu 298 asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese [J]. Hum Genet, 1998,103(1):65-69.
7Tesauro M, Thompson WC, Rogliani P, et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary disease: Cleavage of proteins with aspartate versus glutamate at position 298[J]. Proc Natl Acad Sci USA, 2000, 97(6) :2832 - 2835.
8Harrison DG. Endothelial'control of vasomotion and nitric oxide production :a potential target for risk factor managment[J]. Cardiol Clin, 1996,14(1):1-15.
9[1]The CAFE investigators,for the Anglo-Scandinavian cardiac outcomes investigators.Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes principal results of the conduit artery function evaluation (CAFé)study[J].Circulation,2006,113:1213-1225.
10[2]Staessen JA,Wang JG,Thijs L.Cardiovascular prevention and blood pressure reduction:a quantitative overview updated until 1 March 2003[J].J Hypertens,2003,21:1055-1076.
8Wang D, Zhuang Y, Tian Y, et al. Study of the effects of total flavonoids of astragalus on atherosclerosis formation and potential mechanisms[J]. Oxid Med Cell Longev, 2012(12) :282.
9Sarzani R, Salvi F, Bordieehia M, et al. Carotid artery athero- sclerosis in hypertensive patients with a functional LDL receptor- related protein 6 gene variant[J]. Nutr Metab Cardiovasc Dis, 2011, 21(2): 150.
